Hong Kong, China

David D Tran

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Novoheart International Limited. Active years: 2024-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by David D Tran in Organoid Technology

Introduction

David D Tran is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of organoid technology, particularly through his innovative patent that focuses on devices comprising organoid chambers. His work aims to enhance the understanding and application of organoids in various biological and medical contexts.

Latest Patents

David D Tran holds a patent for "Devices comprising organoid chambers and uses thereof to culture, maintain, monitor or test organoids." This patent describes multi-layer bioreactors designed for growing, maintaining, stimulating, monitoring, and testing organoids and tissues derived from hollow organs. The bioreactors are instrumental in modeling disease processes, monitoring disease progression, and assessing biological effects such as therapeutic efficacy and organotoxicity. Additionally, the patent discloses systems for measuring various parameters of organoid chambers, including volume, pressure, contractility, pump function, and electrophysiology.

Career Highlights

David D Tran is currently associated with Novoheart International Limited, where he continues to advance his research and innovations in organoid technology. His work is pivotal in bridging the gap between laboratory research and clinical applications, particularly in the realm of regenerative medicine and drug testing.

Collaborations

David has collaborated with esteemed colleagues such as Eugene K Lee and Bernard Fermini. Their combined expertise contributes to the innovative projects at Novoheart International Limited, fostering advancements in organoid research.

Conclusion

David D Tran's contributions to organoid technology through his patent and work at Novoheart International Limited highlight the importance of innovation in medical research. His efforts are paving the way for new methodologies in understanding and treating diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…